| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | Belgium | 3 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | WIPO (World Intellectual Property Organization) | 2 | |
| #5 | Brazil | 1 | |
| #6 | Canada | 1 | |
| #7 | China | 1 | |
| #8 | Israel | 1 | |
| #9 | Republic of Korea | 1 | |
| #10 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Driessens Gregory | 15 |
| #2 | Hoofd Catherine | 11 |
| #3 | Cooper Anthony | 10 |
| #4 | Denies Sofie | 10 |
| #5 | Lambolez Florence | 10 |
| #6 | Queva Christophe | 10 |
| #7 | Cuende Julia | 8 |
| #8 | Crosignani Stefano | 5 |
| #9 | Deroose Frederik | 3 |
| #10 | Cauwenberghs Sandra | 3 |
| Publication | Filing date | Title |
|---|---|---|
| US2021069196A1 | Thiocarbamate derivatives as a2a inhibitors, pharmaceutical composition thereof and combinations with anticancer agents | |
| WO2020144178A1 | Anti-tigit antibodies | |
| EP3719040A1 | Anti-tigit antibodies | |
| WO2019023504A1 | Anti-tigit antibodies |